Madrigal Pharmaceuticals
MDGL
#2270
Rank
โ‚ฌ6.35 B
Marketcap
291,51ย โ‚ฌ
Share price
-1.58%
Change (1 day)
38.09%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2023 (TTM): -17,67ย โ‚ฌ

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -17,76ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -16,41ย โ‚ฌ a decrease over its 2021 EPS that were of -13,91ย โ‚ฌ.

EPS history for Madrigal Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-17,67ย โ‚ฌ7.68%
2022-16,41ย โ‚ฌ17.93%
2021-13,91ย โ‚ฌ11.61%
2020-12,47ย โ‚ฌ140.18%
2019-5,19ย โ‚ฌ146.61%
2018-2,10ย โ‚ฌ-12.99%
2017-2,42ย โ‚ฌ-91.03%
2016-26,96ย โ‚ฌ-14.83%
2015-31,66ย โ‚ฌ6.71%
2014-29,67ย โ‚ฌ-29.92%
2013-42,33ย โ‚ฌ19.81%
2012-35,33ย โ‚ฌ6%
2011-33,33ย โ‚ฌ7.53%
2010-31,00ย โ‚ฌ-139.74%
200978,00ย โ‚ฌ-185.4%
2008-91,34ย โ‚ฌ-31.67%
2007-133,67ย โ‚ฌ52.27%
2006-87,78ย โ‚ฌ-27.65%
2005-121,34ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,95ย โ‚ฌ-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,26ย โ‚ฌ-98.55%๐Ÿ‡บ๐Ÿ‡ธ USA